[Chronic granulocytic leukemia (Ph+): among yesterday's myeloproliferative syndromes, today's chronic myeloid leukemias, and tomorrow's mature-element monocellular myelopathies].
Sánchez Fayos
J
J
Servicio de Hematología y Hemoterapia, Fundación Jiménez Díaz, Facultad de Medicina, Universidad Autónoma, Madrid.
Prieto
E
E
Chica Gullón
E
E
D001853:Bone Marrow / Q000473:pathology; D001855:Bone Marrow Diseases / Q000145:classification; D002454:Cell Differentiation; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D018450:Disease Progression; D016044:Fusion Proteins, bcr-abl / Q000032:analysis / Q000235:genetics; D006412:Hematopoietic Stem Cells / Q000473:pathology; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000145:classification* / Q000235:genetics / Q000473:pathology; D009196:Myeloproliferative Disorders / Q000145:classification; D014411:Neoplastic Stem Cells / Q000473:pathology; D010677:Philadelphia Chromosome; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000145:classification / Q000235:genetics / Q000473:pathology
D016044:Fusion Proteins, bcr-abl
Leucemia granulocítica crónica (Ph+) entre los síndromes mieloproliferativos de ayer, las leucemias mieloides crónicas de hoy y las mielopatías monocelulares de elementos maduros de mañana.